DPEP2 and colorectal carcinoma: Apart from cytokines, plasma levels of other immune-related proteins were changed in CRC patients compared to the healthy controls, such as DPEP2 and Peroxiredoxin 6 (PRDX6), which have not been previously reported as plasma diagnostic biomarkers.